Aclaris Therapeutics(ACRS)_个股概要_股票价格_最新资讯_行情走势_历史数据

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

ACRS Aclaris Therapeutics

休市中 05-17 16:00:00 EDT

1.19

+0.01

+0.85%

盘后1.19

+0.000.00%

19:51 EDT

最高1.20	最低1.15	成交量44.64万
今开1.20	昨收1.18	日振幅4.24%
总市值8,481万	流通市值6,060万	总股本7,126万
成交额52.82万	换手率0.88%	流通股本5,092万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"ACRS","market":"US","secType":"STK","nameCN":"Aclaris Therapeutics","latestPrice":1.19,"timestamp":1715976000000,"preClose":1.18,"halted":0,"volume":446399,"hourTrading":{"tag":"盘后","latestPrice":1.19,"preClose":1.19,"latestTime":"19:51 EDT","volume":2399,"amount":2855.269,"timestamp":1715989868936},"delay":0,"floatShares":50922830,"shares":71264786,"eps":-1.092844,"marketStatus":"休市中","marketStatusCode":7,"change":0.01,"latestTime":"05-17 16:00:00 EDT","open":1.2,"high":1.2,"low":1.15,"amount":528213.4463235,"amplitude":0.042373,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-1.092844,"exchange":"NASDAQ","tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1716192000000},"adr":0,"listingDate":1444190400000,"adjPreClose":1.18,"adrRate":0,"preHourTrading":{"tag":"盘前","latestPrice":1.2195,"preClose":1.18,"latestTime":"09:19 EDT","volume":1399,"amount":1665.4319954,"timestamp":1715951973172},"postHourTrading":{"tag":"盘后","latestPrice":1.19,"preClose":1.19,"latestTime":"19:51 EDT","volume":2399,"amount":2855.269,"timestamp":1715989868936},"volumeRatio":0.783401},"requestUrl":"/m/hq/s/ACRS/tweets","defaultTab":"tweets","newsList":[{"id":"2433723441","title":"BUZZ-Aclaris Therapeutics 因第一季度收入下降而下跌","url":"https://stock-news.laohu8.com/highlight/detail?id=2433723441","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2433723441?lang=zh_cn&edition=full","pubTime":"2024-05-08 20:46","pubTimestamp":1715172412,"startTime":"0","endTime":"0","summary":"    5月8日 - ** 药物开发商 Aclaris Therapeutics    股价盘前下跌 5.9% 至 1.26 美元 ** 该公司周二晚些时候公布的第一季度收入为240万美元，去年同期为253万美元 ** 截至 2024 年 3 月 31 日，公司拥有现金、现金等价物和有价证券 1.614 亿美元，而截至 2023 年 12 月 31 日为 1.819 亿美元。** 公司表示，第一季度的大部分现金支出与终止研发项目和之前宣布的裁员有关， 。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2433675883","title":"Aclaris Therapeutics Inc 报告截至一月的季度业绩 - 收益摘要","url":"https://stock-news.laohu8.com/highlight/detail?id=2433675883","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2433675883?lang=zh_cn&edition=full","pubTime":"2024-05-08 05:02","pubTimestamp":1715115778,"startTime":"0","endTime":"0","summary":"   * Aclaris Therapeutics Inc   报告，截至1月底的季度调整后每股亏损24美分，高于去年同期的每股-40美分。八位分析师对该季度的平均预期是每股亏损 29 美分。华尔街预期为每股-37美分至-8美分。* 营收为 240 万美元，同比下降 5.1%；分析师预期为 137 万美元。* Aclaris Therapeutics Inc公布的本季度每股收益为亏损24美分。* 该公司当季亏损 1694 万美元。* Aclaris Therapeutics Inc的股价本季度上涨了5.6%，今年迄今为止上涨了24.8%。* 华尔街对 Aclaris Therapeutics Inc 的 12 个月目标价中位数为 2.00 美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2432157843","title":"Aclaris Therapeutics Inc    预计每股亏损 29 美分 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2432157843","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2432157843?lang=zh_cn&edition=full","pubTime":"2024-05-04 08:18","pubTimestamp":1714781891,"startTime":"0","endTime":"0","summary":"   * Aclaris Therapeutics Inc    将于5月7日公布截至2024年3月31日的季度业绩报告，预计该公司的季度收入将出现下降。* 根据LSEG的数据，6位分析师的平均预期显示，这家总部位于宾夕法尼亚州韦恩市的公司预计营收将从去年同期的253万美元下降45.9%，至136.7万美元。* LSEG 分析师对 Aclaris Therapeutics Inc 的平均预期是每股亏损 29 美分。* 华尔街对 Aclaris Therapeutics Inc 的 12 个月目标价中位数为 2.00 美元，高于其上次收盘价 1.36 美元。5月4日 - 上一季度业绩。除非另有说明，否则所有数据均以美元为单位。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2404899463","title":"BUZZ--美国股票走势-Halozyme、Scorpio Tankers、AMD(超威/超微)","url":"https://stock-news.laohu8.com/highlight/detail?id=2404899463","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2404899463?lang=zh_cn&edition=full","pubTime":"2024-01-17 00:02","pubTimestamp":1705420962,"startTime":"0","endTime":"0","summary":"        *      个股走势的 Eikon 搜索字符串：[STXBZ］        *      The Day Ahead 新闻通讯：          *      The Morning News Call时事通讯：      1月16日 - 华尔街主要股指周二下跌，原因是高盛和摩根士丹利的财报喜忧参半，令投资者对资本市场和交易的健康状况持谨慎态度，银行股因此承压，而特斯拉和苹果的下跌也对股指造成了影响。美东时间 10:37，道琼斯工业平均指数  下跌 0.37%，报 37,452.44 点。标普500指数  和纳斯达克综合指数  下跌0.11%，报14,956.264点。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2402473384","title":"BUZZ--美国股票走势-美国航空公司、石油公司、Salesforce","url":"https://stock-news.laohu8.com/highlight/detail?id=2402473384","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2402473384?lang=zh_cn&edition=full","pubTime":"2024-01-11 22:13","pubTimestamp":1704982434,"startTime":"0","endTime":"0","summary":"        *      个股异动的 Eikon 搜索字符串：[STXBZ］        *      The Day Ahead 新闻通讯：          *      The Morning News Call时事通讯：      1月11日 - 追踪华尔街主要指数的期货周四转为负面，因为消费者通胀率高于预期，抑制了提前开始降息的预期。美东时间9:01，道指电子盘  下跌0.23%，报37847点。标普500指数小型股  下跌0.24%，报4,808.75点；纳斯达克100指数小型股  下跌0.16%，报16,917.5点。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2402429928","title":"BUZZ-皮炎药物试验受挫，BTIG 将 Aclaris 的评级下调至 \"中性\"。","url":"https://stock-news.laohu8.com/highlight/detail?id=2402429928","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2402429928?lang=zh_cn&edition=full","pubTime":"2024-01-11 20:29","pubTimestamp":1704976144,"startTime":"0","endTime":"0","summary":"((自动化翻译由路透提供，请见免责声明 ))    1月11日 - ** 药物开发商Aclaris Therapeutics   股价盘前下跌3.8%至97美分** 券商BTIG将该公司股票评级从 \"买入 \"下调至 \"中性\"** 该公司周三报告说 (link)，在一项中期试验的第二部分中，其特异性皮炎日服一次型药物没有显示出统计学意义** 特应性皮炎会引起瘙痒，导致皮肤发红、肿胀和皲裂** 每日两","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.aclaristx.com","stockEarnings":[{"period":"1week","weight":0.0171},{"period":"1month","weight":-0.0325},{"period":"3month","weight":0},{"period":"6month","weight":0.247},{"period":"1year","weight":-0.8534},{"period":"ytd","weight":0.1333}],"compareEarnings":[{"period":"1week","weight":0.0165},{"period":"1month","weight":0.0577},{"period":"3month","weight":0.0599},{"period":"6month","weight":0.1745},{"period":"1year","weight":0.2629},{"period":"ytd","weight":0.1139}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Aclaris Therapeutics, Inc.于2012年7月在美国特拉华州成立。该公司是一家临床阶段的生物制药公司，专注于开发免疫炎症疾病的新型候选药物。","yearOnYearQuotes":[{"month":1,"riseRate":0.333333,"avgChangeRate":0.159429},{"month":2,"riseRate":0.444444,"avgChangeRate":-0.00511},{"month":3,"riseRate":0.444444,"avgChangeRate":-0.035243},{"month":4,"riseRate":0.444444,"avgChangeRate":-0.000298},{"month":5,"riseRate":0.444444,"avgChangeRate":-0.039829},{"month":6,"riseRate":0.625,"avgChangeRate":-0.011266},{"month":7,"riseRate":0.5,"avgChangeRate":-0.024457},{"month":8,"riseRate":0.5,"avgChangeRate":-0.042275},{"month":9,"riseRate":0.5,"avgChangeRate":0.038413},{"month":10,"riseRate":0.25,"avgChangeRate":0.052818},{"month":11,"riseRate":0.222222,"avgChangeRate":-0.060376},{"month":12,"riseRate":0.777778,"avgChangeRate":0.149317}],"exchange":"NASDAQ","name":"Aclaris Therapeutics","nameEN":"Aclaris Therapeutics"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.22.4","shortVersion":"4.22.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Aclaris Therapeutics(ACRS)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Aclaris Therapeutics(ACRS)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Aclaris Therapeutics,ACRS,Aclaris Therapeutics股票,Aclaris Therapeutics股票老虎,Aclaris Therapeutics股票老虎国际,Aclaris Therapeutics行情,Aclaris Therapeutics股票行情,Aclaris Therapeutics股价,Aclaris Therapeutics股市,Aclaris Therapeutics股票价格,Aclaris Therapeutics股票交易,Aclaris Therapeutics股票购买,Aclaris Therapeutics股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Aclaris Therapeutics(ACRS)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Aclaris Therapeutics(ACRS)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}

公司概况